47 related articles for article (PubMed ID: 15217837)
41. Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia.
Tse W; Meshinchi S; Alonzo TA; Stirewalt DL; Gerbing RB; Woods WG; Appelbaum FR; Radich JP
Blood; 2004 Nov; 104(10):3058-63. PubMed ID: 15217837
[TBL] [Abstract][Full Text] [Related]
42. Core-binding factor (CBF) and MLL-associated primary acute myeloid leukemia: biology and clinical implications.
Strout MP; Marcucci G; Caligiuri MA; Bloomfield CD
Ann Hematol; 1999 Jun; 78(6):251-64. PubMed ID: 10422627
[TBL] [Abstract][Full Text] [Related]
43. The biological and clinical significance of MLL abnormalities in haematological malignancies.
Mitterbauer-Hohendanner G; Mannhalter C
Eur J Clin Invest; 2004 Aug; 34 Suppl 2():12-24. PubMed ID: 15291802
[TBL] [Abstract][Full Text] [Related]
44. Disruption of a homolog of trithorax by 11q23 translocations: leukemogenic and transcriptional implications.
Waring PM; Cleary ML
Curr Top Microbiol Immunol; 1997; 220():1-23. PubMed ID: 9103672
[No Abstract] [Full Text] [Related]
45. MLL: a histone methyltransferase disrupted in leukemia.
Hess JL
Trends Mol Med; 2004 Oct; 10(10):500-7. PubMed ID: 15464450
[TBL] [Abstract][Full Text] [Related]
46.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
47.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
